AstraZeneca’s top medical executive Cristian Massacesi will replace Bristol Myers’ current chief medical officer, Samit ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Supernus ...

Eight New Jersey-based companies have earned spots on U.S. News & World Report’s 2024 list of “Best Companies to Work For." ...

New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

Bristol Myers Squibb has appointed Cristian Massacesi, M.D., as Executive Vice President, Chief Medical Officer, and Head of Development.

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Bristol Myers Squibb has raided AstraZeneca to find its next chief medical officer (CMO), persuading Cristian Massacesi, M.D.

While most commercial office landlords are still hunting for post‑pandemic tenants, there's a sector of the real estate ...

London-based lender Zvilo has increased its debt facility with Fasanara Capital to €75M, up from its original commitment in ...

Strong earnings lift S&P 500 as Consumer Discretionary, Financials rally; Deckers, Newmont surge, Intel, Charter slump.

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...